57 results
6-K
EX-99.2
KZIA
Kazia Therapeutics Limited
13 Oct 23
Current report (foreign)
4:08pm
raisings: The Delisting from ASX and retention of a primary listing on NASDAQ is expected to improve the Company’s access to its institutional investor base
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
11 Oct 23
Kazia Announces Voluntary Delisting from Asx
7:35am
: The delisting from ASX and retention of a primary listing on NASDAQ is expected to improve the Company’s access to its institutional investor base
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
5 Sep 23
Current report (foreign)
7:02am
success. The following employee policies are in place: Code of Business Conduct & Ethics Recruitment and retention Inclusion and diversity Parents … wealth Shareholder wealth in a company engaged in drug development is best delivered through retention of KMPs with an expert level of knowledge of our
6-K
EX-99.1
p9u3zacgjc3o
1 Sep 22
Current report (foreign)
4:07pm
20-F/A
EX-4.11
ul9ny3m 714o8rn5d1
18 Dec 17
Annual report (foreign) (amended)
12:00am